학술논문 – 부산대학교 도서관

학술논문

replay검색결과 돌아가기

search검색화면

Bevacizumab plus paclitaxel versus bevacizumab plus capecitabine as first-line treatment for HER2-negative metastatic breast cancer: interim efficacy results of the randomised, open-label, non-inferiority, phase 3 TURANDOT trial

Document Type

Article

Author

Lang, Istvan; Brodowicz, Thomas; Ryvo, Larisa; Kahan, Zsuzsanna; Greil, Richard; Beslija, Semir; Stemmer, Salomon M; Kaufman, Bella; Zvirbule, Zanete; Steger, Günther G; Melichar, Bohuslav; Pienkowski, Tadeusz; Sirbu, Daniela; Messinger, Diethelm; Zielinski, Christoph

Source

In Lancet Oncology February 2013 14(2):125-133

Subject

Primary Research
Articles

Language

ISSN

1470-2045

Online Access

Full Text (ScienceDirect) Full Text (Clinical Key) Web of Science JCR 저널정보 Scopus Find it@PNU

이메일